Date published: 2025-10-10

00800 4573 8000

SCBT Portrait Logo
Seach Input

LIN-35 Aktivatoren

Assuming "LIN-35" refers to a protein or gene that is integral to a particular biological process, activators of LIN-35 would be molecules that enhance its biological activity. These activators could potentially work by binding directly to the LIN-35 protein, inducing a conformational change that results in increased activity, or by facilitating its interaction with other proteins or substrates. The chemical structures of LIN-35 activators would likely be diverse, as they would need to possess specific characteristics that enable them to interact with distinct structural motifs or domains within LIN-35. These characteristics could include particular arrangements of atoms, charged groups, hydrophobic or hydrophilic elements, or even larger molecular frameworks for protein-protein interaction modulation.

In the realm of research, scientists investigating LIN-35 activators would employ a variety of techniques to understand the interaction between these molecules and the LIN-35 protein. Studies might include computational modeling to predict how these activators could bind to the protein and what effects they may exert on its structure and function. Experimental approaches would likely involve the use of in vitro assays to assess the biochemical consequences of activator binding, such as changes in the enzymatic activity of LIN-35 or alterations in its ability to interact with other cellular components. Advanced analytical techniques like mass spectrometry, circular dichroism, and fluorescence spectroscopy could provide insights into the binding dynamics and structural changes. Furthermore, if the precise structure of the LIN-35 protein were known, techniques such as X-ray crystallography or cryo-electron microscopy might be used to solve the structure of the protein in complex with activator molecules, giving a clear picture of the molecular interactions at play. This could elucidate the mechanism by which these activators enhance LIN-35 activity. Nonetheless, without concrete scientific evidence to define "LIN-35 Activators," this discussion remains purely theoretical and is not grounded in any known chemical classification.

Siehe auch...

ProduktCAS #Katalog #MengePreisReferenzenBewertung

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

Hydroxyharnstoff führt zu DNA-Schäden und kann sich auf Proteine auswirken, die den Zellzyklus regulieren, wodurch sich die Expression von LIN-35 als Teil einer Stressreaktion verändern kann.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Camptothecin induziert DNA-Schäden durch Hemmung der Topoisomerase I, was als zelluläre Reaktion zu Veränderungen in der LIN-35-Expression führen könnte.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposid verursacht über die Hemmung der Topoisomerase II DNA-Strangbrüche und beeinflusst möglicherweise die LIN-35-Expression während der DNA-Schadensreaktion.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$92.00
$260.00
42
(2)

Roscovitin ist ein Cyclin-abhängiger Kinase-Hemmer und kann Auswirkungen auf Zellzyklus-Regulatoren haben, möglicherweise auch auf LIN-35.

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$82.00
$300.00
$1082.00
30
(3)

Aphidicolin ist ein DNA-Polymerase-Inhibitor, der im Rahmen der Aktivierung des Zellzyklus-Checkpoints zu Veränderungen der LIN-35-Expression führen kann.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$40.00
$73.00
$217.00
$242.00
$724.00
$1196.00
39
(2)

Paclitaxel stabilisiert die Mikrotubuli und hält die Zellen in der Mitose an, wobei es möglicherweise die LIN-35-Expression beeinflusst.

Thymidine

50-89-5sc-296542
sc-296542A
sc-296542C
sc-296542D
sc-296542E
sc-296542B
1 g
5 g
100 g
250 g
1 kg
25 g
$48.00
$72.00
$265.00
$449.00
$1724.00
$112.00
16
(1)

Thymidin kann bei hohen Konzentrationen eine Blockade des Zellzyklus in der S-Phase verursachen, was möglicherweise die Expression von LIN-35 beeinflusst.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

Methotrexat hemmt die Dihydrofolatreduktase, was zu einem Stillstand der S-Phase führt, was sich auf die Expression von Zellzyklusregulatoren wie LIN-35 auswirken könnte.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

Nocodazol unterbricht die Mikrotubuli-Polymerisation, was zu einem Stillstand des Zellzyklus führt, was sich auf die LIN-35-Expression auswirken könnte.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

Cisplatin bildet DNA-Addukte, was zu einer Aktivierung der DNA-Schadensreaktion führt, die die LIN-35-Expression als Teil der zellulären Reaktion beeinflussen kann.